Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Polyphenol intake and differentiated thyroid cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Zamora-Ros R, Cayssials V, Franceschi S, Kyrø C, Weiderpass E, Hennings J, Sandström M, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Truong T, Mancini FR, Katzke V, Kühn T, Boeing H, Trichopoulou A, Karakatsani A, Martimianaki G, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Lasheras C, Rodríguez-Barranco M, Amiano P, Colorado-Yohar SM, Ardanaz E, Almquist M, Ericson U, Bueno-de-Mesquita HB, Vermeulen R, Schmidt JA, Byrnes G, Scalbert A, Agudo A, Rinaldi S.

Int J Cancer. 2019 Jul 25. doi: 10.1002/ijc.32589. [Epub ahead of print]

PMID:
31342519
2.

Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using 68Ga-DOTATOC and 68Ga-DOTATATE.

Ilan E, Velikyan I, Sandström M, Sundin A, Lubberink M.

J Nucl Med. 2019 Jul 13. pii: jnumed.119.228072. doi: 10.2967/jnumed.119.228072. [Epub ahead of print]

PMID:
31302632
3.

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE.

Vyakaranam AR, Crona J, Norlén O, Granberg D, Garske-Román U, Sandström M, Fröss-Baron K, Thiis-Evensen E, Hellman P, Sundin A.

Cancers (Basel). 2019 Jun 28;11(7). pii: E909. doi: 10.3390/cancers11070909.

4.

Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3.

Vorobyeva A, Schulga A, Konovalova E, Güler R, Löfblom J, Sandström M, Garousi J, Chernov V, Bragina O, Orlova A, Tolmachev V, Deyev SM.

Sci Rep. 2019 Jun 28;9(1):9405. doi: 10.1038/s41598-019-45795-8.

5.

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington's Disease.

Dunbar GL, Koneru S, Kolli N, Sandstrom M, Maiti P, Rossignol J.

Cell Transplant. 2019 Apr;28(4):460-463. doi: 10.1177/0963689719840662. Epub 2019 Apr 4.

6.

Improved treatment of glioblastoma - changes in survival over two decades at a single regional Centre.

Eriksson M, Kahari J, Vestman A, Hallmans M, Johansson M, Bergenheim AT, Sandström M.

Acta Oncol. 2019 Mar;58(3):334-341. doi: 10.1080/0284186X.2019.1571278. Epub 2019 Feb 7.

PMID:
30732527
7.

Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Zamora-Ros R, Alghamdi MA, Cayssials V, Franceschi S, Almquist M, Hennings J, Sandström M, Tsilidis KK, Weiderpass E, Boutron-Ruault MC, Hammer Bech B, Overvad K, Tjønneland A, Petersen KEN, Mancini FR, Mahamat-Saleh Y, Bonnet F, Kühn T, Fortner RT, Boeing H, Trichopoulou A, Bamia C, Martimianaki G, Masala G, Grioni S, Panico S, Tumino R, Fasanelli F, Skeie G, Braaten T, Lasheras C, Salamanca-Fernández E, Amiano P, Chirlaque MD, Barricarte A, Manjer J, Wallström P, Bueno-de-Mesquita HB, Peeters PH, Khaw KT, Wareham NJ, Schmidt JA, Aune D, Byrnes G, Scalbert A, Agudo A, Rinaldi S.

Eur J Nutr. 2018 Dec 10. doi: 10.1007/s00394-018-1874-z. [Epub ahead of print]

PMID:
30535794
8.

Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

Schnute ME, Wennerstål M, Alley J, Bengtsson M, Blinn JR, Bolten CW, Braden T, Bonn T, Carlsson B, Caspers N, Chen M, Choi C, Collis LP, Crouse K, Färnegårdh M, Fennell KF, Fish S, Flick AC, Goos-Nilsson A, Gullberg H, Harris PK, Heasley SE, Hegen M, Hromockyj AE, Hu X, Husman B, Janosik T, Jones P, Kaila N, Kallin E, Kauppi B, Kiefer JR, Knafels J, Koehler K, Kruger L, Kurumbail RG, Kyne RE Jr, Li W, Löfstedt J, Long SA, Menard CA, Mente S, Messing D, Meyers MJ, Napierata L, Nöteberg D, Nuhant P, Pelc MJ, Prinsen MJ, Rhönnstad P, Backström-Rydin E, Sandberg J, Sandström M, Shah F, Sjöberg M, Sundell A, Taylor AP, Thorarensen A, Trujillo JI, Trzupek JD, Unwalla R, Vajdos FF, Weinberg RA, Wood DC, Xing L, Zamaratski E, Zapf CW, Zhao Y, Wilhelmsson A, Berstein G.

J Med Chem. 2018 Dec 13;61(23):10415-10439. doi: 10.1021/acs.jmedchem.8b00392. Epub 2018 Sep 9.

PMID:
30130103
9.

Behavioral and neurochemical responses derived from dopaminergic intrastriatal grafts in hemiparkinsonian rats engaged in a novel motor task.

Bhupal PK, Anderson KA, Shall GP, Lynn JD, Hoolsema KS, Rossignol J, Dunbar GL, Sandstrom MI.

J Neurosci Methods. 2018 Sep 1;307:149-163. doi: 10.1016/j.jneumeth.2018.06.005. Epub 2018 Jun 18.

PMID:
29924980
10.

Reply to Hearty and Tormey: Use the scientific method to test geologic hypotheses, because rocks do not whisper.

Rovere A, Casella E, Harris DL, Lorscheid T, Nandasena NAK, Dyer B, Sandstrom MR, Stocchi P, D'Andrea WJ, Raymo ME.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):E2904-E2905. doi: 10.1073/pnas.1800534115. Epub 2018 Mar 9. No abstract available.

11.

Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.

Shall G, Menosky M, Decker S, Nethala P, Welchko R, Leveque X, Lu M, Sandstrom M, Hochgeschwender U, Rossignol J, Dunbar G.

Int J Mol Sci. 2018 Mar 2;19(3). pii: E720. doi: 10.3390/ijms19030720.

12.

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.

Garske-Román U, Sandström M, Fröss Baron K, Lundin L, Hellman P, Welin S, Johansson S, Khan T, Lundqvist H, Eriksson B, Sundin A, Granberg D.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988. doi: 10.1007/s00259-018-3945-z. Epub 2018 Mar 1.

13.

Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey.

Sjögreen Gleisner K, Spezi E, Solny P, Gabina PM, Cicone F, Stokke C, Chiesa C, Paphiti M, Brans B, Sandström M, Tipping J, Konijnenberg M, Flux G.

EJNMMI Phys. 2017 Dec 4;4(1):28. doi: 10.1186/s40658-017-0193-4.

14.

Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.

Dossus L, Franceschi S, Biessy C, Navionis AS, Travis RC, Weiderpass E, Scalbert A, Romieu I, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Bonnet F, Fournier A, Fortner RT, Kaaks R, Aleksandrova K, Trichopoulou A, La Vecchia C, Peppa E, Tumino R, Panico S, Palli D, Agnoli C, Vineis P, Bueno-de-Mesquita HBA, Peeters PH, Skeie G, Zamora-Ros R, Chirlaque MD, Ardanaz E, Sánchez MJ, Ramón Quirós J, Dorronsoro M, Sandström M, Nilsson LM, Schmidt JA, Khaw KT, Tsilidis KK, Aune D, Riboli E, Rinaldi S.

Int J Cancer. 2018 Apr 1;142(7):1332-1342. doi: 10.1002/ijc.31172. Epub 2017 Dec 20.

15.

Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force.

Stokke C, Gabiña PM, Solný P, Cicone F, Sandström M, Gleisner KS, Chiesa C, Spezi E, Paphiti M, Konijnenberg M, Aldridge M, Tipping J, Wissmeyer M, Brans B, Bacher K, Kobe C, Flux G.

EJNMMI Phys. 2017 Nov 21;4(1):27. doi: 10.1186/s40658-017-0194-3.

16.

Giant boulders and Last Interglacial storm intensity in the North Atlantic.

Rovere A, Casella E, Harris DL, Lorscheid T, Nandasena NAK, Dyer B, Sandstrom MR, Stocchi P, D'Andrea WJ, Raymo ME.

Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12144-12149. doi: 10.1073/pnas.1712433114. Epub 2017 Oct 30.

17.

Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance.

Sandström M, Garske-Román U, Johansson S, Granberg D, Sundin A, Freedman N.

Acta Oncol. 2018 Apr;57(4):516-521. doi: 10.1080/0284186X.2017.1378431. Epub 2017 Sep 18.

PMID:
28920501
18.

Complex mixtures of dissolved pesticides show potential aquatic toxicity in a synoptic study of Midwestern U.S. streams.

Nowell LH, Moran PW, Schmidt TS, Norman JE, Nakagaki N, Shoda ME, Mahler BJ, Van Metre PC, Stone WW, Sandstrom MW, Hladik ML.

Sci Total Environ. 2018 Feb 1;613-614:1469-1488. doi: 10.1016/j.scitotenv.2017.06.156. Epub 2017 Aug 9.

PMID:
28802893
19.

Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Zamora-Ros R, Béraud V, Franceschi S, Cayssials V, Tsilidis KK, Boutron-Ruault MC, Weiderpass E, Overvad K, Tjønneland A, Eriksen AK, Bonnet F, Affret A, Katzke V, Kühn T, Boeing H, Trichopoulou A, Valanou E, Karakatsani A, Masala G, Grioni S, Santucci de Magistris M, Tumino R, Ricceri F, Skeie G, Parr CL, Merino S, Salamanca-Fernández E, Chirlaque MD, Ardanaz E, Amiano P, Almquist M, Drake I, Hennings J, Sandström M, Bueno-de-Mesquita HBA, Peeters PH, Khaw KT, Wareham NJ, Schmidt JA, Perez-Cornago A, Aune D, Riboli E, Slimani N, Scalbert A, Romieu I, Agudo A, Rinaldi S.

Int J Cancer. 2018 Feb 1;142(3):449-459. doi: 10.1002/ijc.30880. Epub 2017 Jul 24.

20.

Consumption of Fish Is Not Associated with Risk of Differentiated Thyroid Carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.

Zamora-Ros R, Castañeda J, Rinaldi S, Cayssials V, Slimani N, Weiderpass E, Tsilidis KK, Boutron-Ruault MC, Overvad K, Eriksen AK, Tjønneland A, Kühn T, Katzke V, Boeing H, Trichopoulou A, La Vecchia C, Kotanidou A, Palli D, Grioni S, Mattiello A, Tumino R, Sciannameo V, Lund E, Merino S, Salamanca-Fernández E, Amiano P, Huerta JM, Barricarte A, Ericson U, Almquist M, Hennings J, Sandström M, Bueno-de-Mesquita HB, Peeters PH, Khaw KT, Wareham NJ, Schmidt JA, Cross AJ, Riboli E, Scalbert A, Romieu I, Agudo A, Franceschi S.

J Nutr. 2017 Jul;147(7):1366-1373. doi: 10.3945/jn.117.247874. Epub 2017 Jun 7.

21.

A Retrospective Evaluation of Bevacizumab Treatment in Patients with Progressive Malignant Glioma in Northern Sweden.

Sandström M, Laudius M, Lindqvist T, Asklund T, Johansson M.

Anticancer Res. 2017 Apr;37(4):1869-1874.

PMID:
28373454
22.

Detecting lane departures from steering wheel signal.

Sandström M, Lampsijärvi E, Holmström A, Maconi G, Ahmadzai S, Meriläinen A, Hæggström E, Forsman P.

Accid Anal Prev. 2017 Feb;99(Pt A):272-278. doi: 10.1016/j.aap.2016.12.003. Epub 2016 Dec 15.

PMID:
27988449
23.

Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response.

Earp JC, Mehrotra N, Peters KE, Fiorentino RP, Griebel D, Lee SC, Mulberg A, Röhss K, Sandström M, Taylor A, Tornøe CW, Wynn EL, Van der Walt JS, Garnett C.

J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):272-277. doi: 10.1097/MPG.0000000000001467.

PMID:
27875488
24.

Meat and haem iron intake in relation to glioma in the European Prospective Investigation into Cancer and Nutrition study.

Ward HA, Gayle A, Jakszyn P, Merritt M, Melin B, Freisling H, Weiderpass E, Tjonneland A, Olsen A, Dahm CC, Overvad K, Katzke V, Kühn T, Boeing H, Trichopoulou A, Lagiou P, Kyrozis A, Palli D, Krogh V, Tumino R, Ricceri F, Mattiello A, Bueno-de-Mesquita B, Peeters PH, Quirós JR, Agudo A, Rodriguez-Barranco M, Larrañaga N, Huerta JM, Barricarte A, Sonestedt E, Drake I, Sandström M, Travis RC, Ferrari P, Riboli E, Cross AJ.

Eur J Cancer Prev. 2018 Jul;27(4):379-383. doi: 10.1097/CEJ.0000000000000331.

25.

Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.

Ilan E, Sandström M, Velikyan I, Sundin A, Eriksson B, Lubberink M.

J Nucl Med. 2017 May;58(5):744-749. doi: 10.2967/jnumed.116.180380. Epub 2016 Oct 27.

26.

Complex mixtures of Pesticides in Midwest U.S. streams indicated by POCIS time-integrating samplers.

Van Metre PC, Alvarez DA, Mahler BJ, Nowell L, Sandstrom M, Moran P.

Environ Pollut. 2017 Jan;220(Pt A):431-440. doi: 10.1016/j.envpol.2016.09.085. Epub 2016 Sep 30.

PMID:
27697376
27.

Unanimous versus partial rejection: How the number of excluders influences the impact of ostracism in children.

Sandstrom MJ, Deutz MH, Lansu TA, van Noorden TH, Karremans JC, Cillessen AH.

Aggress Behav. 2017 Apr;43(2):190-203. doi: 10.1002/ab.21674. Epub 2016 Sep 14.

PMID:
27629385
28.

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.

Sandström M, Lindskog K, Velikyan I, Wennborg A, Feldwisch J, Sandberg D, Tolmachev V, Orlova A, Sörensen J, Carlsson J, Lindman H, Lubberink M.

J Nucl Med. 2016 Jun;57(6):867-71. doi: 10.2967/jnumed.115.169342. Epub 2016 Feb 9.

29.

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.

Sörensen J, Velikyan I, Sandberg D, Wennborg A, Feldwisch J, Tolmachev V, Orlova A, Sandström M, Lubberink M, Olofsson H, Carlsson J, Lindman H.

Theranostics. 2016 Jan 1;6(2):262-71. doi: 10.7150/thno.13502. eCollection 2016.

30.

Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors.

Honarvar H, Westerlund K, Altai M, Sandström M, Orlova A, Tolmachev V, Karlström AE.

Theranostics. 2016 Jan 1;6(1):93-103. doi: 10.7150/thno.12766. eCollection 2016.

31.

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases.

Barbier CE, Garske-Román U, Sandström M, Nyman R, Granberg D.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1425-31. doi: 10.1007/s00259-015-3264-6. Epub 2015 Dec 3.

PMID:
26631239
32.

Method dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.

Sandström M, Ilan E, Karlberg A, Johansson S, Freedman N, Garske-Román U.

EJNMMI Phys. 2015 Dec;2(1):24. doi: 10.1186/s40658-015-0127-y. Epub 2015 Oct 24.

33.

Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study.

Sen A, Tsilidis KK, Allen NE, Rinaldi S, Appleby PN, Almquist M, Schmidt JA, Dahm CC, Overvad K, Tjønneland A, Rostgaard-Hansen AL, Clavel-Chapelon F, Baglietto L, Boutron-Ruault MC, Kühn T, Katze VA, Boeing H, Trichopoulou A, Tsironis C, Lagiou P, Palli D, Pala V, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HA, Peeters PH, Hjartåker A, Lund E, Weiderpass E, Quirós JR, Agudo A, Sánchez MJ, Arriola L, Gavrila D, Gurrea AB, Tosovic A, Hennings J, Sandström M, Romieu I, Ferrari P, Zamora-Ros R, Khaw KT, Wareham NJ, Riboli E, Gunter M, Franceschi S.

Br J Cancer. 2015 Sep 1;113(5):840-7. doi: 10.1038/bjc.2015.280. Epub 2015 Aug 27.

34.

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers.

Garousi J, Lindbo S, Nilvebrant J, Åstrand M, Buijs J, Sandström M, Honarvar H, Orlova A, Tolmachev V, Hober S.

Cancer Res. 2015 Oct 15;75(20):4364-71. doi: 10.1158/0008-5472.CAN-14-3497. Epub 2015 Aug 21.

35.

Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study.

Zamora-Ros R, Rinaldi S, Tsilidis KK, Weiderpass E, Boutron-Ruault MC, Rostgaard-Hansen AL, Tjønneland A, Clavel-Chapelon F, Mesrine S, Katzke VA, Kühn T, Förster J, Boeing H, Trichopoulou A, Lagiou P, Klinaki E, Masala G, Sieri S, Ricceri F, Tumino R, Mattiello A, Peeters PH, Bueno-de-Mesquita HB, Engeset D, Skeie G, Argüelles M, Agudo A, Sánchez MJ, Chirlaque MD, Barricarte A, Chamosa S, Almquist M, Tosovic A, Hennings J, Sandström M, Schmidt JA, Khaw KT, Wareham NJ, Cross AJ, Slimani N, Byrnes G, Romieu I, Riboli E, Franceschi S.

Int J Cancer. 2016 Jan 1;138(1):65-73. doi: 10.1002/ijc.29693. Epub 2015 Jul 30.

36.

Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors.

Andersson KG, Rosestedt M, Varasteh Z, Malm M, Sandström M, Tolmachev V, Löfblom J, Ståhl S, Orlova A.

Oncol Rep. 2015 Aug;34(2):1042-8. doi: 10.3892/or.2015.4046. Epub 2015 Jun 9.

PMID:
26059265
37.

Recurrent enlarged nuchal translucency: first trimester presentation of a familial 15q26→qter deletion.

Reiss R, Ahern D, Sandstrom M, Wilkins-Haug L.

Am J Med Genet A. 2015 Mar;167A(3):612-6. doi: 10.1002/ajmg.a.36913.

PMID:
25691414
38.

Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.

Ilan E, Sandström M, Wassberg C, Sundin A, Garske-Román U, Eriksson B, Granberg D, Lubberink M.

J Nucl Med. 2015 Feb;56(2):177-82. doi: 10.2967/jnumed.114.148437. Epub 2015 Jan 15.

39.

Presymptomatic glutamate levels in prefrontal cortex in the Hdh(CAG150) mouse model of Huntington's disease.

Wolfram-Aduan A, Altemus M, Wickwire JH, Sandstrom MI.

J Huntingtons Dis. 2014;3(4):387-99. doi: 10.3233/JHD-140114.

PMID:
25575960
40.

Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression.

Mitran B, Altai M, Hofström C, Honarvar H, Sandström M, Orlova A, Tolmachev V, Gräslund T.

Amino Acids. 2015 Feb;47(2):303-15. doi: 10.1007/s00726-014-1859-z. Epub 2014 Nov 27.

41.

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.

Altai M, Honarvar H, Wållberg H, Strand J, Varasteh Z, Rosestedt M, Orlova A, Dunås F, Sandström M, Löfblom J, Tolmachev V, Ståhl S.

Eur J Med Chem. 2014 Nov 24;87:519-28. doi: 10.1016/j.ejmech.2014.09.082. Epub 2014 Sep 26.

42.

188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment.

Altai M, Wållberg H, Honarvar H, Strand J, Orlova A, Varasteh Z, Sandström M, Löfblom J, Larsson E, Strand SE, Lubberink M, Ståhl S, Tolmachev V.

J Nucl Med. 2014 Nov;55(11):1842-8. doi: 10.2967/jnumed.114.140194. Epub 2014 Oct 2.

43.

Device and method of optically orienting biaxial crystals for sample preparation.

Thomas T, Rossman GR, Sandstrom M.

Rev Sci Instrum. 2014 Sep;85(9):093105. doi: 10.1063/1.4894555.

PMID:
25273705
44.

[Autism spectrum disorders in severe cerebral palsy often discovered late. Retrospective review of 10 years of medical records].

Dahl M, Bergsten C, Hammarberg A, Sandström M, Strinnholm M.

Lakartidningen. 2014 Aug 6-19;111(32-33):1296-8. Swedish. No abstract available.

45.

Odor and noise intolerance in persons with self-reported electromagnetic hypersensitivity.

Nordin S, Neely G, Olsson D, Sandström M.

Int J Environ Res Public Health. 2014 Aug 27;11(9):8794-805. doi: 10.3390/ijerph110908794.

46.

Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study.

Zamora-Ros R, Rinaldi S, Biessy C, Tjønneland A, Halkjaer J, Fournier A, Boutron-Ruault MC, Mesrine S, Tikk K, Fortner RT, Boeing H, Förster J, Trichopoulou A, Trichopoulos D, Papatesta EM, Masala G, Tagliabue G, Panico S, Tumino R, Polidoro S, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Lund E, Argüelles M, Agudo A, Molina-Montes E, Navarro C, Barricarte A, Larrañaga N, Manjer J, Almquist M, Sandström M, Hennings J, Tsilidis KK, Schmidt JA, Khaw KT, Wareham NJ, Romieu I, Byrnes G, Gunter MJ, Riboli E, Franceschi S.

Int J Cancer. 2015 Mar 1;136(5):1218-27. doi: 10.1002/ijc.29067. Epub 2014 Jul 22.

47.

A Balint-inspired reflective forum in oncology for medical residents: main themes during seven years.

Salander P, Sandström M.

Patient Educ Couns. 2014 Oct;97(1):47-51. doi: 10.1016/j.pec.2014.06.008. Epub 2014 Jun 25.

PMID:
25034638
48.

Exposure vs. response of blood pressure in patients with rheumatoid arthritis following treatment with fostamatinib.

Boström E, Öhrn F, Hanze E, Sandström M, Martin P, Wählby-Hamrén U.

J Clin Pharmacol. 2014 Dec;54(12):1337-46. doi: 10.1002/jcph.341. Epub 2014 Jun 25.

PMID:
24895144
49.

Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.

Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Østergaard JN, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quirós JR, Agudo A, Molina E, Larrañaga N, Navarro C, Ardanaz E, Manjer J, Almquist M, Sandström M, Hennings J, Khaw KT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, Gunter M, Riboli E, Franceschi S.

J Natl Cancer Inst. 2014 Jun;106(6):dju097.

PMID:
24824312
50.

First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.

Sörensen J, Sandberg D, Sandström M, Wennborg A, Feldwisch J, Tolmachev V, Åström G, Lubberink M, Garske-Román U, Carlsson J, Lindman H.

J Nucl Med. 2014 May;55(5):730-5. doi: 10.2967/jnumed.113.131243. Epub 2014 Mar 24.

Supplemental Content

Loading ...
Support Center